Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia
A Pilot Study Evaluating the Safety and Efficacy of a Fractionated Thulium Laser and Topical Platelet Rich Plasma vs. Platelet Rich Plasma Injection for the Treatment of Male Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Withdrawn
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Montefiore Medical Center
- Participants (registry)
- —
- Start
- July 2022 (planned)
- Primary completion
- December 2024
- Study completion
- December 2025
- Last registry update
- August 2022
- Countries
- —
Conditions studied: Androgenetic Alopecia
Interventions: Fractionated Thulium laser, LaseMD Lutronic Laser, Autologous Platelet Rich Plasma Injection, Autologous Platelet Rich Plasma Topical Application
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.